Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	409	96	515	1,093	2,207	970
Market Cap Growth	69.76%	-81.28%	-52.90%	-50.50%	127.45%	-17.20%
Enterprise Value	397	-1	204	614	1,554	607
Last Close Price	1.96	0.54	3.14	7.50	15.61	8.37
PS Ratio	7.25	0.55	4.62	9.87	18.67	9.47
PB Ratio	10.45	1.16	1.74	2.91	4.44	2.24
P/TBV Ratio	4.61	1.16	2.49	3.88	5.56	2.85
P/FCF Ratio	-	-	-	-	14.23	-
P/OCF Ratio	-	-	-	-	12.99	-
EV/Sales Ratio	7.60	-	1.83	5.54	13.15	5.92
EV/FCF Ratio	-	-	-	-	10.01	-
Debt / Equity Ratio	0.71	0.46	0.15	0.13	0.08	0.10
Debt / FCF Ratio	-	-	-	-	0.27	-
Asset Turnover	0.32	0.48	0.17	0.13	0.15	0.17
Quick Ratio	1.15	1.72	2.53	2.99	4.51	5.73
Current Ratio	1.35	1.98	2.69	3.12	4.60	5.80
Return on Equity (ROE)	-154.94%	-136.47%	-57.37%	-40.86%	-26.04%	-23.85%
Return on Assets (ROA)	-46.35%	-17.60%	-19.59%	-13.80%	-10.27%	-10.71%
Return on Capital (ROIC)	-64.79%	-27.91%	-33.04%	-23.80%	-15.93%	-15.57%
Earnings Yield	-32.97%	-267.59%	-37.37%	-16.32%	-5.48%	-9.81%
FCF Yield	-28.64%	-255.31%	-47.38%	-23.48%	7.03%	-17.01%
Buyback Yield / Dilution	-13.05%	-13.02%	-6.76%	-7.53%	-19.92%	-15.65%
Total Shareholder Return	-13.05%	-13.02%	-6.76%	-7.53%	-19.92%	-15.65%

Source: S&P Capital IQ. Standard template. Financial Sources.